Equity Holdings of Tata India Pharma & Healthcare Fund
Here is the most recent list of
equity holdings in the Tata India Pharma & Healthcare Fund's portfolio
as of 28 Feb 2025 . The fund's AUM is 842.81 crores, of which equity holdings constitute 98.05%.
| Name of the Equity | Holding Percentage |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 11.61% |
| AUROBINDO PHARMA LTD. | 7.10% |
| CIPLA LTD. | 6.25% |
| LUPIN LTD. | 6.22% |
| DIVI'S LABORATORIES LTD. | 5.21% |
| FORTIS HEALTHCARE LTD. | 4.75% |
| APOLLO HOSPITALS ENTERPRISE LTD. | 3.98% |
| Zydus Lifesciences Ltd | 3.74% |
| Aster DM Healthcare Ltd | 3.31% |
| Alkem Laboratories Ltd | 3.17% |
| WOCKHARDT LTD. | 2.88% |
| HealthCare Global Enterprises Ltd | 2.57% |
| Laurus Labs Ltd | 2.41% |
| AJANTA PHARMA LTD. | 2.13% |
| TORRENT PHARMACEUTICALS LTD. | 1.89% |
| IPCA LABORATORIES LTD. | 1.75% |
| FDC LTD. | 1.63% |
| Orchid Pharma Ltd | 1.52% |
| Dr. Lal PathLabs Ltd | 1.46% |
| INDOCO REMEDIES LTD. | 1.19% |
| Metropolis Healthcare Ltd | 1.11% |
| Piramal Pharma Ltd | 1.03% |
| Ami Organics Ltd | 0.98% |
| COROMANDEL INTERNATIONAL LTD. | 0.91% |
| Sanofi India Ltd | 0.87% |
| Medplus Health Services Ltd | 0.77% |
| Procter & Gamble Health Ltd | 0.73% |
| Syngene International Ltd | 0.63% |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD. | 0.55% |
| DEEPAK NITRITE LTD. | 0.30% |